Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Long-Term Investments (2021 - 2025)

Historic Long-Term Investments for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to $128.1 million.

  • Krystal Biotech's Long-Term Investments fell 1580.92% to $128.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $128.1 million, marking a year-over-year decrease of 1580.92%. This contributed to the annual value of $128.1 million for FY2025, which is 1580.92% down from last year.
  • According to the latest figures from Q4 2025, Krystal Biotech's Long-Term Investments is $128.1 million, which was down 1580.92% from $133.1 million recorded in Q3 2025.
  • In the past 5 years, Krystal Biotech's Long-Term Investments registered a high of $152.1 million during Q4 2024, and its lowest value of $4.6 million during Q4 2022.
  • In the last 5 years, Krystal Biotech's Long-Term Investments had a median value of $62.0 million in 2023 and averaged $66.3 million.
  • As far as peak fluctuations go, Krystal Biotech's Long-Term Investments plummeted by 9282.13% in 2022, and later soared by 153766.82% in 2024.
  • Quarter analysis of 5 years shows Krystal Biotech's Long-Term Investments stood at $64.4 million in 2021, then crashed by 92.82% to $4.6 million in 2022, then skyrocketed by 1240.71% to $62.0 million in 2023, then soared by 145.53% to $152.1 million in 2024, then decreased by 15.81% to $128.1 million in 2025.
  • Its Long-Term Investments stands at $128.1 million for Q4 2025, versus $133.1 million for Q3 2025 and $138.8 million for Q2 2025.